Media
Displaying 31 - 40 of 57
Santen and jCyte conclude an exclusive licensing agreement for jCell, a cell therapy for retinitis pigmentosa
As the COVID-19 pandemic continues to impact families, communities and businesses, healthcare systems are re-configuring to address the challenge.
On Wednesday 22 April 2020, over 700 EMEA colleagues and 40 guests from our headquarters in Japan, joined Santen’s first ever Virtual Conference.
As a healthcare company that is well represented across the globe, Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.
Santen EMEA held its European Ocular Surface Summit on Friday 6 March as a one-day virtual meeting for 45 ophthalmologists from across Europe.
As a healthcare company that is well represented across the globe, Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.
Santen presents surgical offering at ICGS 2020
Santen and Verily establish joint venture to develop and commercialise unique ophthalmic devices
The New Year is off to a great start with Santen EMEA picking up the Gold award for Innovation at the UK PM Society Awards 2020.
Santen Pharmaceutical partnership agreement with ITU supporting ITU and WHO initiative “Be He@lthy, Be Mobile” in ophthalmology
